These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 31028563)
61. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888 [TBL] [Abstract][Full Text] [Related]
62. Hypertension in obesity: is leptin the culprit? Simonds SE; Cowley MA Trends Neurosci; 2013 Feb; 36(2):121-32. PubMed ID: 23333346 [TBL] [Abstract][Full Text] [Related]
63. The sympathetic nervous system in obesity hypertension. Lohmeier TE; Iliescu R Curr Hypertens Rep; 2013 Aug; 15(4):409-16. PubMed ID: 23677623 [TBL] [Abstract][Full Text] [Related]
65. Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue. Wellhöner P; Hörster R; Jacobs F; Sayk F; Lehnert H; Dodt C Int J Obes (Lond); 2012 May; 36(5):703-8. PubMed ID: 21629206 [TBL] [Abstract][Full Text] [Related]
66. Role of Orexin-A in Hypertension and Obesity. Imperatore R; Palomba L; Cristino L Curr Hypertens Rep; 2017 Apr; 19(4):34. PubMed ID: 28353077 [TBL] [Abstract][Full Text] [Related]
67. A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats. Hsiung HM; Hertel J; Zhang XY; Smith DP; Smiley DL; Heiman ML; Yang DD; Husain S; Mayer JP; Zhang L; Mo H; Yan LZ Endocrinology; 2005 Dec; 146(12):5257-66. PubMed ID: 16166226 [TBL] [Abstract][Full Text] [Related]
68. Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex. Dalmasso C; Leachman JR; Osborn JL; Loria AS Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R379-R389. PubMed ID: 31868518 [TBL] [Abstract][Full Text] [Related]
69. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369 [TBL] [Abstract][Full Text] [Related]
70. Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin. Masuo K Curr Hypertens Rep; 2002 Apr; 4(2):112-8. PubMed ID: 11884266 [TBL] [Abstract][Full Text] [Related]
71. New perspectives on the origin of hypertension; the role of the hypothalamic melanocortin system. Samuelsson AM Exp Physiol; 2014 Sep; 99(9):1110-5. PubMed ID: 25210109 [TBL] [Abstract][Full Text] [Related]
72. The sympathetic nervous system and baroreflexes in hypertension and hypotension. Izzo JL; Taylor AA Curr Hypertens Rep; 1999 Jun; 1(3):254-63. PubMed ID: 10981075 [TBL] [Abstract][Full Text] [Related]
73. Origin of Aberrant Blood Pressure and Sympathetic Regulation in Diet-Induced Obesity. Lim K; Barzel B; Burke SL; Armitage JA; Head GA Hypertension; 2016 Aug; 68(2):491-500. PubMed ID: 27296999 [TBL] [Abstract][Full Text] [Related]
74. Sympathetic nervous system response to intake. Welle S Am J Clin Nutr; 1995 Nov; 62(5 Suppl):1118S-1122S. PubMed ID: 7484930 [TBL] [Abstract][Full Text] [Related]
79. State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Mark AL; Correia M; Morgan DA; Shaffer RA; Haynes WG Hypertension; 1999 Jan; 33(1 Pt 2):537-41. PubMed ID: 9931161 [TBL] [Abstract][Full Text] [Related]
80. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]